Pressure is building for HHS to enforce its 2020 rule requiring insurers to count cost-sharing assistance paid by drug manufacturers towards annual patient cost-sharing limits, with Senate appropriators requesting in their fiscal 2025 HHS funding bill report a briefing on CMS’ enforcement. The bill, while unlikely to become law in its current form, demonstrates that copay accumulator concerns are a priority, at least in the Democratic-run Senate. The House version of the HHS spending bill does not mention the issue...